Diabete, penne smart - Malattie eosinofile

from Salute e Società · host Marco Caracciolo

1. In Italia, Il 26 per cento delle persone con diabete assume insulina, ma l’80 per cento non riesce a raggiungere il target glicemico necessario per scongiurare le complicanze. 2. Mepolizumab è una terapia di precisione per quattro malattie infiammatorie.

Episode metadata supplied by the publisher feed · Published Apr 22, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Diabete, penne smart - Malattie eosinofile

0:00 6:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Salute e Società?

This episode is 6 minutes long.

When was this Salute e Società episode published?

This episode was published on April 22, 2023.

Can I download this Salute e Società episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!